Weather Alert  

"Storm Watch" ...Storm watch in effect from late Sunday night through late Monday night... The National Weather Service in Upton has issued a storm watch... which is in effect from late Sunday night through late Monday night. * Winds and seas...northeast winds 40 to 45 kt with gusts up to 60 kt on ocean...35 to 40 kt with gusts to 50 kt on the nearshore waters. Seas 16 to 21 feet on the ocean...and 5 to 10 ft on Long Island Sound. Precautionary/preparedness actions... A storm watch is issued when the risk of storm force winds of 48 to 63 kt has significantly increased...but the specific timing and/or location is still uncertain. It is intended to provide additional lead time for mariners who may wish to consider altering their plans. -- Friday Jan.20 17,11:00 PM

The Rottenstein Law Group LLP Notes Anticoagulant Drug Xarelto® Surpasses Pradaxa in the Number of Reported Injuries

The Rottenstein Law Group LLP, a national personal injury law firm with over 25 years of experience, notes an increase in the number of adverse event reports involving the anticoagulant drug Xarelto® over other similarly ...

Print Email

Rockville Centre, NY - June 24th, 2014 - The Rottenstein Law Group LLP, a national personal injury law firm with over 25 years of experience, notes an increase in the number of adverse event reports involving the anticoagulant drug Xarelto® over other similarly prescribed drugs.

In 2013, the U.S. Food and Drug Administration (FDA) received almost 700 adverse event reports submitted by individuals who claimed to have a serious adverse side effect while taking Xarelto® (rivaroxaban), as compared to 528 for Pradaxa (dabigatran).  Data shows that the number of individuals being prescribed these drugs is estimated at about 4 million for the year, with Xarelto® prescriptions outnumbering Pradaxa prescriptions by two-to-one. Anticoagulants, or “blood thinners” are considered high-risk prescription drugs because they can cause excessive internal bleeding and other health risks in some patients.

“We are concerned about the increasing number of adverse events associated with Xarelto®,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “We want consumers to understand that they have rights when it comes to the healthcare products they use, particularly prescription drugs that could cause life-threatening injuries.”

The Rottenstein Law Group LLP encourages anyone who believes they, or a loved one have been injured by Xarelto® to visit the firm’s new website, for valuable information about the drug’s dangers. Users are invited to request a no-cost case evaluation by filling out the confidential form found on the site’s home page.

About The Rottenstein Law Group LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

For More Information, Please Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
100 Merrick Road, Suite 226W
Rockville Centre, NY 11570
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle@rotlaw.com
plus.google.com/106070664376281033016